Loading company…
Riskpilot
← Back to search
Sign in
Get full access
QSI PHARMA A/S
A/S
Dissolved
CVR 26444071
Industriparken 55
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik · NACE 721900
Est. 2002
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2012
—
EBITDA margin
—
Equity ratio
99.7%
Financial strength
Net profit 2012
DKK 170K
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2012
Key figures
Annual report 2012
Revenue
—
—
EBITDA
DKK -25K
—
Net profit
DKK 170K
—
Total assets
DKK 26,3M
—
Equity
DKK 26,3M
—
Employees
—
—
Company information
Legal name
QSI PHARMA A/S
CVR number
26444071
Legal form
Aktieselskab
NACE code
721900 · Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Founded
29. januar 2002
Share capital
DKK 1.250.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2012-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden i forening med den administrerende direktør eller af tre bestyrelsesmedlemmer i forening.
Contact
Address
Industriparken 55
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Companies in Ballerup
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2012
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2012
Income statement
DKK thousands
Item
2012
Revenue
—
Staff expenses
-0
EBITDA
-25
Depreciation & amort.
-0
EBIT
-25
Net financials
252
Profit before tax
227
Tax
57
Net profit
170
Balance sheet
DKK thousands
Item
2012
Total assets
26.346
Equity
26.264
Long-term debt
0
Short-term debt
82
Total debt
82
Financial ratios
5-year trend
EBITDA margin
-2500000.0%
This company
15.8%
Market median
-15822885% vs market
2012
2012
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
2012
2012
Return on equity
0.6%
This company
18.4%
Market median
-97% vs market
2012
2012
Net profit margin
17000000.0%
This company
8.1%
Market median
+209876443% vs market
2012
2012
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2012
2012
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2012
2012
Annual reports & filings
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
LO
Lars Olsen
Management
Management
2002
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
KJ
Karin Jexner Hamberg
Board of Directors
2002
—
—
KM
Kristian Merser
Chairman
2012
—
—
TD
Tore Duvold
Board of Directors
2011
—
—
PM
Peter Møller Nielsen
Chairman
2008
—
—
JH
Jens Hansen
Board of Directors
2002
—
—
PR
Poul Rødbroe Rasmussen
Chairman
2002
—
—
PK
Per Klemm
Board of Directors
2005
—
—
NS
Nina Sølver Henning
Board of Directors
2008
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of QSI PHARMA A/S also hold positions in
0
other companies.
Person
Role here
Other companies
Lars Olsen
Management
0 companies
Karin Jexner Hamberg
Board of Directors
0 companies
Kristian Merser
Chairman
0 companies
Tore Duvold
Board of Directors
0 companies
Peter Møller Nielsen
Chairman
0 companies
Jens Hansen
Board of Directors
0 companies
Poul Rødbroe Rasmussen
Chairman
0 companies
Per Klemm
Board of Directors
0 companies
Nina Sølver Henning
Board of Directors
0 companies